Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check5 days agoChange DetectedThe page revision was bumped from v3.6.4 to v3.6.5, indicating an updated version of the page content. This change does not alter the study details or visible information.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page shows an updated revision tag indicating a small maintenance update to the page's metadata and versioning.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update or correction to the study page. This reflects an internal version bump rather than a substantive addition to study content or user-facing features.SummaryDifference0.0%

- Check48 days agoChange DetectedA new revision tag, v3.6.2, was added and the old tag, v3.6.0, was removed. This indicates a minor update to the page's underlying system rather than changes to the study content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now displays a recruitment status note ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), while the Intervention/Treatment heading is standardized and the Revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small metadata update to the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.